[Efficacy and safety of bevacizumab plus capecitabine for metastatic colorectal cancer].

Xiaonan Wu(Xiamen University), Meizhen Zhou(Beijing Hospital), Bin Ai, Li Ding(Hubei University of Chinese Medicine), Yunbo Zhao(University of Science and Technology of China), Lin Li(Shenyang Pharmaceutical University), Jianyu Wu(Beijing Hospital)
Cited by 2


Related Papers